Lallemand inaugurates new research and development laboratories

Lallemand proudly announces the inauguration of its new laboratories in France, increasing its capacity by over 800 square meters.

This significant expansion enhances its interdisciplinary research and development capabilities at the Blagnac and Beauzelle sites.

The investment of over 1.7 million euros will enable the seventy scientists and technicians working at these two sites to continue their involvement in ambitious research and development programs.

This expansion, coupled with the acquisition of new, state-of-the-art equipment, will enable Lallemand to strengthen its bioprocess innovation cluster and accelerate the development of next-generation strains. The research departments of the following business units: Specialty Cultures, Oenology, Animal Health, Human Health, and Plant Care, will benefit from these new spaces and technologies, expanding the possibilities offered by the microorganisms they are studying.

Antoine Chagnon, CEO of Lallemand, declares: “At Lallemand, we firmly believe that microbial solutions can help us meet the challenges of today and tomorrow. To realize this potential, we reinvest 3 to 5% of our sales in research and development every year to support our teams of over 400 researchers in a dozen centers around the world. The expansion of our laboratories in the Toulouse region is part of this ongoing drive to extend our capabilities both internally and with external collaborators. We are proud to celebrate this important milestone with them today.”

Lallemand invited numerous partners, political representatives, scientists, and media to celebrate this important milestone and to explore its new, operational premises during the inauguration day on September 4, 2024, at its site in the Toulouse region.